Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Consensus on Severe Lung Cancer-The Second Edition.

Translational lung cancer research·2026
Same author

A Pulley-Assisted Ligature Technique for Safe and Versatile Vascular Division During Uniportal Video-Assisted Thoracic Surgery.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

The genomic origin of the unique chaetognath body plan.

Nature·2025
Same author

Association of human adenovirus load and viral genotype diversity with respiratory disease severity in children: a systematic review and meta-analysis.

Translational pediatrics·2025
Same author

Virtual rat web: A versatile simulation tool for pharmacology education in a variety of settings.

European journal of pharmacology·2025
Same author

Analysis and exploration of regulatory mechanisms and potential prognostic biomarkers in squamous cell carcinoma of the lung by expression profiling.

Translational cancer research·2025

Related Experiment Video

Updated: Jan 30, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.0K

Stereotactic Radiotherapy for Oligometastasis.

Sotaro Otake1, Taichiro Goto2

  • 1Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Kofu 400-8506, Japan. sotaro.otake@gmail.com.

Cancers
|January 26, 2019
PubMed
Summary

Oligometastatic disease, a limited metastatic state, benefits from focused local treatments. Stereotactic ablative body radiotherapy (SABR) offers an effective, minimally invasive alternative to surgery for improving patient survival.

Keywords:
canceroligometastasisoncologystereotactic ablative body radiotherapysurgery

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.4K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.7K

Related Experiment Videos

Last Updated: Jan 30, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.0K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.4K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.7K

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Oligometastatic disease represents an intermediate stage between localized cancer and widespread metastasis.
  • Current treatment aims for long-term local control and improved survival.
  • Historically, surgery was used, but lacks proven survival benefits from randomized trials.

Purpose of the Study:

  • To review the historical context and rationale for local treatment of oligometastatic disease.
  • To explore the implementation and efficacy of Stereotactic Ablative Body Radiotherapy (SABR) for oligometastatic conditions.

Main Methods:

  • Review of historical treatment approaches for oligometastatic disease.
  • Discussion of the evolution and application of focused, high-dose radiation therapies.
  • Analysis of evidence supporting SABR for extracranial metastases.

Main Results:

  • While surgery has been used, prospective trials have not confirmed survival benefits.
  • Stereotactic radiosurgery has shown survival benefits for solitary brain metastases.
  • SABR is increasingly adopted for extracranial oligometastases due to efficacy and minimal invasiveness.

Conclusions:

  • Local therapies are crucial for managing oligometastatic disease.
  • SABR presents a promising, evidence-supported modality for treating oligometastases.
  • Further research and implementation of SABR can enhance patient outcomes.